WE Buchan

WE Communications (formerly WE Buchan) is a leading global independent communications and integrated marketing agency with a specialized focus on the healthcare, technology, and consumer sectors. In Australia, the firm is a prominent service provider for the life sciences industry, offering strategic counsel in corporate affairs, investor relations, and product communications. The agency supports a diverse portfolio of clients, ranging from global pharmaceutical giants like AbbVie and Novo Nordisk to innovative biotech firms such as Vaxxas and Moderna. Originally founded as Buchan Consulting in 1985, the firm became WE Buchan following a majority acquisition by the US-based WE Communications in 2016 and fully transitioned to the global WE brand in 2019. The agency is recognized for its ability to translate complex scientific data into compelling narratives that drive stakeholder engagement and business growth. It operates offices in Melbourne and Sydney, serving as a critical link for companies navigating the Australian healthcare landscape.